🟡 60/100

Review before taking

  • Potassium Iodide: 130mg is 118.2× the Tolerable Upper Intake Level (1.1mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Potassium Iodide: 130mg is 118.2× the Tolerable Upper Intake Level (1.1mg)

This product has a low safety score because the amount of potassium iodide in each tablet is over 100 times higher than the recommended maximum daily limit.

Label Data

2 Tablet(s) Serving Size
90 Servings
Mineral Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

⚠️ Exceeds Tolerable Upper Intake Level by 118.2× (UL: 1.1 mg) 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 130mg UL 1.1mg

Other Ingredients

Microcrystalline Cellulose Magnesium Stearate Dicalcium Phosphate Croscarmellose Sodium Silicon Dioxide

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (74% of products) Nutrient (53% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested Use: For adults over the age of 18, take 130 mg (2 tablets) per day. Individuals who are 12-18 years old and over 150 lbs should take 130 mg (2 tablets). Individuals who are under 18 years old and under 150 pounds should take 65 mg (1 tablet). Individuals under 12 years old regardless of weight should take 65 mg (1 tablet). For short term use only, do not take for longer than 2 weeks unless directly by your physician, state, or local health officials.

⚠️ Warnings & Precautions

Product Information: Potassium Iodide should only be taken in emergency situations when directed by your physician, state, or local health authorities. A larger amount of Potassium Iodide does not create an extra benefit so only take the recommended dose for the period of time suggested by local or state health officials.

For short term use only, do not take for longer than 2 weeks unless directly by your physician, state, or local health officials.

Warning: Consult your physician before use if you are pregnant or nursing, taking any other supplements/medications, or have any medical conditions (especially any thyroid conditions).

Keep out of reach of children.

Discontinue use and consult your doctor immediately if any adverse reactions occur. Do not use Potassium Iodide and operate heavy machinery until you know how it affects you.

Keep out of reach of children.

Do not exceed 4 tablets per day.

For short-term use only, do not use for longer than two weeks.

🧪 Formulation Notes

Potassium Iodide Tablets 130 mg per serving

Short-Term Use Emergency Supplement

Additional Information

Storage: Store in a cool, dark place after opening. Do not freeze or expose to moisture or heat above room temperature.

Product Details

UPC / SKU 0 50033 27269 7
DSLD Entry Date 2024-09-25
Product Type Mineral
Form Tablet or Pill
DSLD ID 315691
Data Updated 2026-04-11

Research Evidence

292 Research Sources
57 Avg Quality Score
160 Meta Analysis
70 Systematic Review
36 Rct
8 Cochrane Review
8 Clinical Trial
3 Regulatory Source
2 Narrative Review
2 Other
1 Guideline
1 Openfda Safety
A Umbilical cord antiseptics for preventing sepsis and death among newborns
Meta Analysis The Cochrane database of systematic reviews 2026
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019
A Interventions for cutaneous molluscum contagiosum
Meta Analysis The Cochrane database of systematic reviews 2017
A Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections: A Systematic Review and Meta-Analysis
Meta Analysis JAMA network open 2026
B Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Meta Analysis JAMA otolaryngology-- head & neck surgery 2021
B Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Meta Analysis European journal of nuclear medicine and molecular imaging 2022
B Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials
Meta Analysis The Lancet. Infectious diseases 2022
B Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
B Interventions for ingrowing toenails
Meta Analysis The Cochrane database of systematic reviews 2012
B Interventions for the management of malignant pleural effusions: a network meta-analysis
Systematic Review The Cochrane database of systematic reviews 2016
View all evidence for Iodine →

Compare Similar Products

View all Iodine products →